BICO Group subsidiary Cytena today announced the launch of its C.Station platform for automating the development of stable cell lines.
Cytena said in a news release that C.Station is a user-friendly platform that covers the entire cell line development workflow, from single-cell cloning of transfected cells to the selection of high-producing clones and upscaling.